Search our Database of Scientific Publications and Authors

I’m looking for a
    Scleroderma-like fibrosing disorders.
    • Authors:
    • Francesco Boin
      Johns Hopkins University School of Medicine
      United States
      Laura K Hummers
      Johns Hopkins University School of Medicine
      United States
    Rheum Dis Clin North Am 2008 Feb;34(1):199-220; ix
    Division of Rheumatology, Johns Hopkins University School of Medicine, 5200 Eastern Avenue, Mason F. Lord Building, Center Tower, Suite 4100, Room 405, Baltimore, MD 21224, USA.
    Many conditions presenting with clinical hard skin and tissue fibrosis can be confused with systemic sclerosis (scleroderma). These disorders have very diverse etiologies and often an unclear pathogenetic mechanism. Distinct clinical characteristics, skin histology, and disease associations may allow one to distinguish these conditions from scleroderma and from each other. A prompt diagnosis is important to spare patients from ineffective treatments and inadequate management. This article highlights nephrogenic systemic fibrosis (nephrogenic fibrosing dermopathy), eosinophilic fasciitis (Shulman's syndrome), scleromyxedema, and scleredema. These often are detected in the primary care setting and referred to rheumatologists for further evaluation. Rheumatologists must be able to promptly recognize them to provide valuable prognostic information and appropriate treatment options for affected patients.

    Similar Publications

    Scleroderma mimics.
    Curr Rheumatol Rep 2012 Feb;14(1):39-46
    BIDMC, Division of Rheumatology and Lupus Center, Harvard University School of Medicine, Boston, MA 02215, USA.
    Scleroderma is a rare systemic autoimmune disease with multiple organ manifestations, including skin fibrosis. The groups of disorders classified as scleroderma mimics share the common thread of skin thickening but are otherwise quite incongruous in terms of underlying disease process and other organ involvement. This article reviews the clinical presentation, etiology, and treatment options available for scleroderma mimics, including morphea, scleredema, diabetic cheiroarthropathy, scleromyxedema, nephrogenic systemic fibrosis, and eosinophilic fasciitis. Read More
    Localized cutaneous fibrosing disorders.
    Rheum Dis Clin North Am 2013 May 16;39(2):347-64. Epub 2013 Mar 16.
    Division of Immunology and Rheumatology, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305, USA.
    This article acquaints the reader with disorders of the skin that might mimic systemic sclerosis but whose pathology is localized to the skin and/or has extracutaneous manifestations that are different than systemic sclerosis. These disorders include localized scleroderma (morphea), eosinophilic fasciitis, scleredema, scleromyxedema, nephrogenic systemic fibrosis, and chronic graft-versus-host disease. Particular emphasis is placed on clinical and histopathologic features that help the clinician differentiate between these disorders. Read More
    Nephrogenic systemic fibrosis: an unusual scleroderma-like fibrosing disorder.
    Rheumatol Int 2010 Aug 20;30(10):1389-91. Epub 2009 Aug 20.
    Neurology Unit, S. Croce Hospital, Mondovì (CN), Italy.
    Nephrogenic systemic fibrosis (NSF) is a fibrosing disorder, recently described in patients with advanced chronic kidney disease, usually after exposure to gadolinium (Gd)-based contrast agents, characterized by progressive fibrotic involvement mainly of the skin. At clinical examination, the cutaneous findings of NSF may partly resemble those of systemic sclerosis. However, the different topographic distribution of the skin thickening and hardening, usually involving the limbs and trunk, whilst sparing the face, the lack of serologic abnormalities and the distinctive histopathological findings allow this new disease entity to be distinguished from systemic sclerosis and other scleroderma-like fibrosing disorders (scleromyxedema, scleredema, eosinophilic fasciitis, etc. Read More
    Morphological clues in the diagnosis of sclerodermiform dermatitis.
    Am J Dermatopathol 2014 Jun;36(6):449-64
    *Pathology Specialist, Department of Cellular Pathology, Hospital El Bierzo, Ponferrada, Spain; and Departments of †Resident (M.G-T.), Assistant Dermatologist (A.L.R-V.) Department of Dermatology, ‡Associate Professor, Pathology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, INER/CIENI, Hospital Angeles Lomas, Centro Medico ABC, Mexico City, México.
    In this report, we review 5 sclerodermiform cutaneous conditions: eosinophilic fasciitis, systemic nephrogenic fibrosis, scleredema, scleromyxedema, and toxic oil syndrome. We emphasize the morphological differences between the conditions and some morphological clues that are important to differential diagnosis. Read More